These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 22133678)
1. Epitope mapping of antibodies against TDP-43 and detection of protease-resistant fragments of pathological TDP-43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Tsuji H; Nonaka T; Yamashita M; Masuda-Suzukake M; Kametani F; Akiyama H; Mann DM; Tamaoka A; Hasegawa M Biochem Biophys Res Commun; 2012 Jan; 417(1):116-21. PubMed ID: 22133678 [TBL] [Abstract][Full Text] [Related]
2. Intracellular dynamics of Ataxin-2 in the human brains with normal and frontotemporal lobar degeneration with TDP-43 inclusions. Watanabe R; Higashi S; Nonaka T; Kawakami I; Oshima K; Niizato K; Akiyama H; Yoshida M; Hasegawa M; Arai T Acta Neuropathol Commun; 2020 Oct; 8(1):176. PubMed ID: 33115537 [TBL] [Abstract][Full Text] [Related]
3. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Hasegawa M; Arai T; Nonaka T; Kametani F; Yoshida M; Hashizume Y; Beach TG; Buratti E; Baralle F; Morita M; Nakano I; Oda T; Tsuchiya K; Akiyama H Ann Neurol; 2008 Jul; 64(1):60-70. PubMed ID: 18546284 [TBL] [Abstract][Full Text] [Related]
5. Novel monoclonal antibodies to normal and pathologically altered human TDP-43 proteins. Kwong LK; Irwin DJ; Walker AK; Xu Y; Riddle DM; Trojanowski JQ; Lee VM Acta Neuropathol Commun; 2014 Mar; 2():33. PubMed ID: 24690345 [TBL] [Abstract][Full Text] [Related]
6. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration. Takeda T Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544 [TBL] [Abstract][Full Text] [Related]
7. [Molecular dissection of TDP-43 in ALS and FTLD]. Hasegawa M; Arai T; Nonaka T; Tsuji H; Yamashita M; Hosokawa M; Kametani F; Tamaoka A; Akiyama H Rinsho Shinkeigaku; 2010 Nov; 50(11):937-9. PubMed ID: 21921518 [TBL] [Abstract][Full Text] [Related]
8. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis. Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806 [TBL] [Abstract][Full Text] [Related]
9. Molecular dissection of TDP-43 proteinopathies. Hasegawa M; Nonaka T; Tsuji H; Tamaoka A; Yamashita M; Kametani F; Yoshida M; Arai T; Akiyama H J Mol Neurosci; 2011 Nov; 45(3):480-5. PubMed ID: 21678031 [TBL] [Abstract][Full Text] [Related]
11. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death. Xiao S; Sanelli T; Chiang H; Sun Y; Chakrabartty A; Keith J; Rogaeva E; Zinman L; Robertson J Acta Neuropathol; 2015 Jul; 130(1):49-61. PubMed ID: 25788357 [TBL] [Abstract][Full Text] [Related]
12. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies. Geser F; Lee VM; Trojanowski JQ Neuropathology; 2010 Apr; 30(2):103-12. PubMed ID: 20102519 [TBL] [Abstract][Full Text] [Related]
13. Phosphorylated TDP-43 becomes resistant to cleavage by calpain: A regulatory role for phosphorylation in TDP-43 pathology of ALS/FTLD. Yamashita T; Teramoto S; Kwak S Neurosci Res; 2016 Jun; 107():63-9. PubMed ID: 26723245 [TBL] [Abstract][Full Text] [Related]
14. TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: From pathomechanisms to therapeutic strategies. Ho PC; Hsieh TC; Tsai KJ Ageing Res Rev; 2024 Sep; 100():102441. PubMed ID: 39069095 [TBL] [Abstract][Full Text] [Related]
15. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Wils H; Kleinberger G; Janssens J; Pereson S; Joris G; Cuijt I; Smits V; Ceuterick-de Groote C; Van Broeckhoven C; Kumar-Singh S Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3858-63. PubMed ID: 20133711 [TBL] [Abstract][Full Text] [Related]
16. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy. Arai T; Hasegawa M; Nonoka T; Kametani F; Yamashita M; Hosokawa M; Niizato K; Tsuchiya K; Kobayashi Z; Ikeda K; Yoshida M; Onaya M; Fujishiro H; Akiyama H Neuropathology; 2010 Apr; 30(2):170-81. PubMed ID: 20102522 [TBL] [Abstract][Full Text] [Related]
17. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Igaz LM; Kwong LK; Xu Y; Truax AC; Uryu K; Neumann M; Clark CM; Elman LB; Miller BL; Grossman M; McCluskey LF; Trojanowski JQ; Lee VM Am J Pathol; 2008 Jul; 173(1):182-94. PubMed ID: 18535185 [TBL] [Abstract][Full Text] [Related]
18. Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD-TDP subtypes. Neumann M; Frick P; Paron F; Kosten J; Buratti E; Mackenzie IR Acta Neuropathol; 2020 Nov; 140(5):645-658. PubMed ID: 32778941 [TBL] [Abstract][Full Text] [Related]
19. [Significance of the TDP-43 deposition in FTLD-U and ALS]. Hasegawa M; Arai T; Nonaka T; Kametani F; Yoshida M; Hashizume Y; Beach TG; Morita M; Nakano I; Oda T; Tsuchiya K; Akiyama H Rinsho Shinkeigaku; 2008 Nov; 48(11):994-7. PubMed ID: 19198142 [TBL] [Abstract][Full Text] [Related]
20. The role of mutant TAR DNA-binding protein 43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Janssens J; Kleinberger G; Wils H; Van Broeckhoven C Biochem Soc Trans; 2011 Aug; 39(4):954-9. PubMed ID: 21787329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]